Tauopathies, including Alzheimer’s disease (AD) and some forms of frontotemporal dementia (FTD), are characterised by heterogenous deposition of phosphorylated tau aggregates in different neural cell types and brain regions (Kovacs, 2020). This evidence concerns the gene MAPT and Alzheimer disease.